Advertisement

Topics

Companies Related to "Effects of an Exercise Program in Patients With Hypertensive: a Randomized Clinical Trial Chronic Kidney Disease" [Most Relevant Company Matches] [Advanced Search Results] RSS

12:33 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Effects of an Exercise Program in Patients With Hypertensive: a Randomized Clinical Trial Chronic Kidney Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Effects Exercise Program Patients With Hypertensive Randomized Clinical" Companies 1–25 of 9,200+

Relevant

Summit Cancer Solutions

Summit Cancer Solutions, Inc. is a 501(c)(3) non-profit organization dedicated to providing cancer survivors with affordable and empowering exercise programs in a healthy, positive and non-intimidating environment within their community. Founded in 2002 by four-time breast cancer survivor Karen Hornbostel, who lost her own personal battle in 2006, Summit h...


ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Physitrack Limited

Physitrack is a global health technology platform, offering physiotherapists, exercise physiologist, chiropractors and other health care professionals a new standard in home exercise prescription as part of the overall rehabilitation process. Personalised exercise programs, which are easily shared with colleagues, as well as a direct feedback loop with pat...


Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

InVasc Therapeutics, Inc.

InVasc Therapeutics, Inc., headquartered in Tucker, Georgia, is a biopharmaceutical company developing drugs to mitigate risks associated with cardiometabolic diseases. Cardiovascular and metabolic diseases such as diabetes, hypertension, stroke and dyslipidemia are the leading causes of morbidity and mortality worldwide. The Company plans to file an IND l...

Genta Incorporated

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company’s research platform: DNA/RNA-based Medicines and Small Molecules. Genasense® (oblimersen sodium) Injection is the Company's lead com...

Physical Therapy Pal

Physical Therapy Pal (PT PAL) is the first clinical HIPAA-compliant mobile application used between physical therapists and patients. PT PAL helps improve outcomes by engaging patients in their therapy. PT PAL gives visibility into patient regimen adherence and the ability to monitor and modify therapy prescriptions remotely. PT PAL is an aid ...

Santarus, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians. The company’s current commercial efforts are focused on GLUMETZA® (metformin HCl extended release tablets), which ...

OPTIFAST Program

The OPTIFAST Program utilizes a stimuli-narrowing dietary intervention in combination with behavioral therapy techniques, nutrition and exercise education along with medical supervision. Stimuli narrowing limits the variety and quantity of available foods and flavors to decrease appetite. Together, the main components of the OPTIFAST Program--stimuli narrowing and behavioral therapy-have helped mo...

Esperion Therapeutics Inc.

Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, LDL-cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. ETC-1002, Esperion's lead product candidate, is a unique, first-in-class, orally avail...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

Stentys

Based in Princeton, N.J., and Paris, Stentys has developed a new generation of stents for the treatment of acute myocardial infarction. Founded by Jacques Séguin, M.D., Ph.D., (founder of CoreValve, which was acquired last year by Medtronic for $700 million) and by Gonzague Issenmann, Stentys received CE Mark of its flagship products in 2010 and will st...

Azaya Therapeutics Inc.

Azaya Therapeutics, Inc. is an oncology company focused on developing more effective cancer treatments through its novel nanotechnology platform. Azaya’s patented Protein Stabilized Liposomes™ (PSL) platform allows for high-dose delivery of potent cytotoxics with potentially lower side effects. ATI-1123, is a novel liposomal encapsulation of Doce...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

Biothera Pharmaceuticals Inc.

Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime PGG, a first-in-class, mid-clinical stage cancer immunotherapy that orchestrates an integrated anti-cancer immune response in combination with checkpoint inhibitors and tumor-targeting and anti-angiogenesis monoclonal antibodies. Imprime PGG has been well-tolerated in tri...

Jennerex Biotherapeutics

Jennerex is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594, currently in an international randomized Phase 2 clinical trial for patients with primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse a...

Activbody, Inc.

Activbody™ aspires to make the world healthier with fitness and health technologies designed to make exercise convenient for all while monitoring muscle development. Its cornerstone product, Activ5, allows anyone at any fitness level to exercise virtually anywhere through five-minute full body workouts, all while tracking, guiding and even entertainin...

Life Time Pharmaceuticals Incorporated

LifeTime™ Pharmaceuticals, a private clinical-stage pharmaceutical company, focuses on the development of drugs that are safe enough for long-term, chronic administration. Compounds currently under development seek to eliminate and prevent recurrence of potentially fatal cancers and infectious syndromes. Human clinical trial results presented at several scientific meetings (see below) have shown...

Breathe Easy Respiratory Solutions, Inc.

Breathe Easy Respiratory Solutions, Inc. has developed a holistic disease management program for treating respiratory patients with the goal of improving and saving lives. Licensed respiratory therapists evaluate the patient either before hospital discharge or at home to encourage compliance and discourage readmissions. The therapist has personal contact w...

Brilliant Biometrics

Brilliant Biometrics is dedicated to developing wearable technology that enhances the well-being of individuals and communities. We are a diverse and creative team of engineers, industrial designers, artists, psychologists and exercise enthusiasts. After experimenting with many exercise heart rate monitors, we realized that it is actually very difficult to...

DOR BioPharma, Inc.

DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec(R) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of GI GVHD, a comm...

Hoy Health, LLC

Hoy Health LLC, is a first-of-its-kind health-tech platform that provides a comprehensive and integrated bilingual healthcare support ecosystem to medically underserved patients offering solutions relative to medication access, medication adherence, tele-health and chronic condition management programs. Hoy Health’s core businesses include HoyMEDS, a ...

AZOVA, Inc.

AZOVA Inc.’s Collaborative Clinical Care Platform™ is empowering true collaborative care between pharmacists, physicians and patients. This platform enables healthcare providers to collaborate in any clinical program. Patients benefit from more efficient delivery of care, price transparency, and interoperable access to their various doctors, nurses ...

Gene Smart

Gene Smart Wellness is a preventative healthcare company dedicated to pioneering real world approaches that empower individuals to take control of their whole health in order to live abundantly. The company's innovations include its Living Abundantly Community Wellness Program, the Gene Smart Omega-3 Index Home Blood Test and the Gene Smart Anti-Inflammation Diet & Exercise Program. More informati...

Jazzercise, Inc.

Judi Sheppard Missett, who turned her love of jazz dance into a worldwide dance exercise phenomenon, founded the Jazzercise dance fitness program in 1969. She has advanced the business opportunities of women and men in the fitness industry by growing the program into an international franchise business that today, hosts a network of 7,800 instructors teach...


More From BioPortfolio on "Effects of an Exercise Program in Patients With Hypertensive: a Randomized Clinical Trial Chronic Kidney Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks